{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for ixazomib root_notes_note in Note (approximate match)
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M006
(2021)
Source URL:
First approved in 2021
Source:
M006
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M020
(2020)
Source URL:
First approved in 2020
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M005
(2019)
Source URL:
First approved in 2016
Source:
DOUXO CALM MOUSSE by Ceva Sante Animale
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Clorpactin WCS-90 by United-Guardian, Inc.
(1955)
Source URL:
First approved in 1955
Source:
Clorpactin WCS-90 by United-Guardian, Inc.
Source URL:
Class:
MIXTURE
Status:
US Approved OTC
Source:
21 CFR 349.14(b)(3) ophthalmic:emollient paraffin
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
Spermaceti U.S.P.
(1921)
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
First approved in 2001
Source:
Walgreens Urinary Pain Relief by Walgreens Co
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NDA019885
(1991)
Source URL:
First approved in 1991
Source:
NDA019885
Source URL:
Class:
STRUCTURALLY DIVERSE